ALICR — ICeram SA Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for ICeram SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.62 | 1.52 | 1.56 | 1.41 | 0.992 |
Cost of Revenue | |||||
Gross Profit | 1.04 | 1.06 | 1.2 | 1.4 | 0.533 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.19 | 3.02 | 2.23 | 2.59 | 2.25 |
Operating Profit | -2.56 | -1.5 | -0.67 | -1.18 | -1.26 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.71 | -1.51 | -0.719 | -1.23 | -1.38 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.69 | -1.46 | -0.679 | -0.937 | -1.1 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.76 | -1.53 | -0.772 | -0.937 | -1.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.76 | -1.53 | -0.772 | -0.937 | -1.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -9.61 | -5.59 | -2.93 | -2.51 | -4.21 |
Dividends per Share |